F11.250 Opioid dependence with opioid-induced psychotic disorder with delusions

Name of the Condition

• Opioid Dependence with Opioid-Induced Psychotic Disorder with Delusions

Summary

Opioid dependence with opioid-induced psychotic disorder with delusions is a condition characterized by compulsive opioid use, cravings, and continued use despite negative consequences, accompanied by psychotic symptoms directly attributable to opioid use. The psychotic features specifically include delusions, which are false beliefs not explained by another mental disorder or substance. This condition often disrupts personal, social, and occupational functioning.

Causes

Opioid dependence typically develops from prolonged opioid use, whether for medical purposes (e.g., pain management) or recreational use. Repeated exposure alters brain chemistry, leading to tolerance and dependence. The psychotic disorder component arises from the direct neurotoxic effects of opioids on the central nervous system, which can trigger acute or chronic psychotic symptoms in susceptible individuals.

Risk Factors

• History of substance use disorders.
• Genetic predisposition to addiction.
• Chronic pain treated with opioids.
• Environmental exposure to opioids.
• Co-occurring mental health conditions (e.g., depression, anxiety).
• High-dose or long-term opioid use.

Symptoms

• Intense cravings for opioids.
• Tolerance (needing higher doses for the same effect).
• Withdrawal symptoms (e.g., nausea, muscle aches, anxiety) when reducing use.
• Delusions (false beliefs) directly related to opioid use.
• Neglect of responsibilities or social activities.
• Continued use despite harm.

Diagnosis

Diagnosis involves clinical assessment, including patient history, substance use patterns, and symptom evaluation. Healthcare providers may use criteria from the DSM-5 or similar diagnostic frameworks to confirm opioid dependence and the presence of opioid-induced psychotic symptoms. The psychotic symptoms must be directly attributable to opioid use and not better explained by another condition.

Treatment Options

Treatment typically includes a combination of medication-assisted therapy (e.g., buprenorphine, methadone) to manage withdrawal and cravings, along with antipsychotic medications to address psychotic symptoms. Psychotherapy, such as cognitive-behavioral therapy, and support groups may also be recommended to address underlying issues and promote recovery.

Prognosis and Follow-Up

Prognosis varies depending on the severity of dependence, adherence to treatment, and presence of co-occurring conditions. Regular follow-up is essential to monitor progress, adjust treatment, and address any relapses. Long-term management often involves ongoing support and lifestyle modifications.

Complications

• Worsening of psychotic symptoms.
• Increased risk of overdose.
• Social and occupational impairment.
• Co-occurring mental health disorders.
• Physical health issues related to opioid use.

Lifestyle & Prevention

• Avoiding non-prescribed opioid use.
• Using opioids only as directed by a healthcare provider.
• Seeking help for substance use concerns early.
• Engaging in stress-reduction techniques and healthy coping mechanisms.
• Building a support network of family, friends, or support groups.

When to Seek Professional Help

Seek professional help if experiencing intense cravings, difficulty reducing opioid use, or the onset of psychotic symptoms like delusions. Immediate medical attention is necessary for signs of overdose, such as difficulty breathing or loss of consciousness.

Tips for Medical Coders

When coding for F11.250, ensure documentation supports both opioid dependence and the presence of opioid-induced psychotic disorder with delusions. The psychotic symptoms must be directly attributable to opioid use and not better explained by another condition. Review clinical notes for clear evidence of delusions and their relationship to opioid use to justify the code.